Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-21-000211
Filing Date
2021-11-02
Accepted
2021-11-02 19:24:42
Documents
1
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163589546612485.html 4  
1 FORM 4 wf-form4_163589546612485.xml 4 17656
  Complete submission text file 0001725160-21-000211.txt   19238
Mailing Address C/O AISLING CAPITAL 888 SEVENTH AVENUE, 30TH FLOOR NEW YORK NY 10106
Business Address
SUN ANTHONY Y (Reporting) CIK: 0001377952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 211373119

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations